New hope to fight diabetes risk from schizophrenia meds?
NCT ID NCT03575000
Summary
This small pilot study is testing if adding a drug called bromocriptine is safe and can help control blood sugar in people with schizophrenia who are also at risk for diabetes. The 15 participants will take bromocriptine alongside their regular antipsychotic medication for 6 weeks. The main goal is to see if it's well-tolerated and might help prevent or delay the onset of type 2 diabetes in this high-risk group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VA Pittsburgh Healthcare System
Pittsburgh, Pennsylvania, 15240, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.